Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons

International Journal of Infectious Diseases

Volumn 30, Issue , 2015, Pages 115-121

  Su, Wei Ju ^a,b,c   Chan, Ta Chien ^d   Chuang, Pei Hung ^e   Liu, Yu Lun ^a   Lee, Ping Ing ^c   Liu, Ming Tsan ^a   Chuang, Jen Hsiang ^a,f  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d RESEARCH CENTER FOR HUMANITIES AND SOCIAL SCIENCES   (Taiwan)

^e The Taiwan Foundation for Poison Control   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Case control studies; Influenza surveillance; Influenza vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

AGE; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; GENDER; HUMAN; INFANT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PHYSICIAN; PRESCHOOL CHILD; REGISTER; SEASON; TAIWAN; THROAT CULTURE; VIRUS ISOLATION; WINTER; EPIDEMIOLOGICAL MONITORING; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; META ANALYSIS; STATISTICAL MODEL;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; SEASONS; TAIWAN;

EID: 84918562947     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.11.011     Document Type: Article

References (50)

1. Cromer D., van Hoek A.J., Jit M., Edmunds W.J., Fleming D., Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect 2014, 68:363-371.
2. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008, 57:1-60.
3. Heinonen S., Silvennoinen H., Lehtinen P., Vainionpaa R., Ziegler T., Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011, 11:23-29.
4. Cowling B.J., Chan K.H., Feng S., Chan E.L., Lo J.Y., Peiris J.S., et al. The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. Vaccine 2014, 32:5278-5284.
5. Jefferson T., Smith S., Demicheli V., Harnden A., Rivetti A., Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005, 365:773-780.
6. Orenstein E.W., De Serres G., Haber M.J., Shay D.K., Bridges C.B., Gargiullo P., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631.
7. th Expert Consult edition 2008, 259-290. Saunders Elsevier. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
8. Smith S., Demicheli V., Di Pietrantonj C., Harnden A.R., Jefferson T., Matheson N.J., et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2006, CD004879.
9. Shih S.R., Chen G.W., Yang C.C., Yang W.Z., Liu D.P., Lin J.H., et al. Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol 2005, 43:1651-1661.
10. Kelly H., Carville K., Grant K., Jacoby P., Tran T., Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009, 4:e5079.
11. Joshi A.Y., Iyer V.N., St Sauver J.L., Jacobson R.M., Boyce T.G. Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study. Vaccine 2009, 27:4457-4461.
12. Fleming D.M., Andrews N.J., Ellis J.S., Bermingham A., Sebastianpillai P., Elliot A.J., et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010, 64:1062-1067.
13. Hsieh Y.C., Chen H.Y., Yen J.J., Liu D.P., Chang L.Y., Lu C.Y., et al. Influenza in Taiwan: seasonality and vaccine strain match. J Microbiol Immunol Infect 2005, 38:238-243.
14. Wang S.F., Lee Y.M., Chan Y.J., Liu H.F., Yen Y.F., Liu W.T., et al. Influenza A virus in Taiwan, 1980-2006: phylogenetic and antigenic characteristics of the hemagglutinin gene. J Med Virol 2009, 81:1457-1470.
15. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
16. Jacoby P, Kelly H. Is it necessary to adjust for calendar time in a test negative design? Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-8. Vaccine 2014; 32:2942.
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
18. Lewis S., Clarke M. Forest plots: trying to see the wood and the trees. BMJ 2001, 322:1479-1480.
19. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
20. Schwarzer G. meta: Meta-Analysis with R. R package version 1. 6-1 ed. 2010, R Foundation for Statistical Computing, Vienna, Austria.
21. Kavanagh K., Robertson C., McMenamin J. Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach. PLoS One 2011, 6:e28743.
22. Kwong J.C., Campitelli M.A., Gubbay J.B., Peci A., Winter A.L., Olsha R., et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis 2013, 57:820-827.
23. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available at: (accessed October 18, 2014). http://www.cochrane-handbook.org/.
24. The compelling need for game-changing influenza vaccines: an analysis of the influenza vaccine enterprise and recommendations for the future. Center for Infectious Disease Research and Policy; 2012. Available at: (accessed October 19, 2014). http://www.cidrap.umn.edu/sites/default/files/public/downloads/ccivi_report.pdf.
25. Jimenez-Jorge S., de Mateo S., Delgado-Sanz C., Pozo F., Casas I., Garcia-Cenoz M., et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis 2013, 13:441.
26. Belongia E.A., Sundaram M.E., McClure D.L., Meece J.K., Ferdinands J., VanWormer J.J. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine 2014 Jun 21, [Epub ahead of print].
27. Nunes B., Machado A., Guiomar R., Pechirra P., Conde P., Cristovao P., et al. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups. Vaccine 2014, 32:4443-4449.
28. Aguilar I., Reyes M., Martinez-Baz I., Guevara M., Albeniz E., Belza M., et al. Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain. Euro Surveill 2012, 17. pii:20154.
29. Jefferson T., Rivetti A., Harnden A., Di Pietrantonj C., Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008, CD004879.
30. Negri E., Colombo C., Giordano L., Groth N., Apolone G., La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005, 23:2851-2861.
31. Yang P., Thompson M.G., Ma C., Shi W., Wu S., Zhang D., et al. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. Vaccine 2014, 32:5285-5289.
32. Menniti-Ippolito F., Da Cas R., Traversa G., Santuccio C., Felicetti P., Tartaglia L., et al. Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy. Vaccine 2014, 32:4466-4470.
33. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342:232-239.
34. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000, 342:225-231.
35. Fujieda M., Maeda A., Kondo K., Fukushima W., Ohfuji S., Kaji M., et al. Influenza vaccine effectiveness and confounding factors among young children. Vaccine 2008, 26:6481-6485.
36. Zangwill K.M., Belshe R.B. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 2004, 23:189-197.
37. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001, 344:889-896.
38. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M., Shone L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008, 122:911-919.
39. Neuzil K.M., Wright P.F., Mitchel E.F., Griffin M.R. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000, 137:856-864.
40. Szilagyi P.G., Fairbrother G., Griffin M.R., Hornung R.W., Donauer S., Morrow A., et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 2008, 162:943-951.
41. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine-Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep 2008, 57:393-398. Centers for Disease Control and Prevention.
42. Tricco A.C., Chit A., Soobiah C., Hallett D., Meier G., Chen M.H., et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013, 11:153.
43. Mangtani P., Cumberland P., Hodgson C.R., Roberts J.A., Cutts F.T., Hall A.J. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004, 190:1-10.
44. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59:1-62.
45. Englund J.A., Walter E.B., Gbadebo A., Monto A.S., Zhu Y., Neuzil K.M. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics 2006, 118:e579-e585.
46. Neuzil K.M., Jackson L.A., Nelson J., Klimov A., Cox N., Bridges C.B., et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006, 194:1032-1039.
47. Halloran M.E., Longini I.M., Gaglani M.J., Piedra P.A., Chu H., Herschler G.B., et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol 2003, 158:305-311.
48. Houser K.V., Pearce M.B., Katz J.M., Tumpey T.M. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. J Virol 2013, 87:13480-13489.
49. McLean H.Q., Thompson M.G., Sundaram M.E., Meece J.K., McClure D.L., Friedrich T.C., et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 2014 Sep 29, [Epub ahead of print].
50. Lone N.I., Simpson C., Kavanagh K., Robertson C., McMenamin J., Ritchie L., et al. Seasonal influenza vaccine effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set. BMJ Open 2012, 2:e001019.